tiprankstipranks
Cannomed Medical Cannabis Industries Ltd. (IL:GEFR)
TASE:GEFR
Israel Market

Cannomed (GEFR) Income Statement

0 Followers

Cannomed Income Statement

Last quarter (Q4 2025), Cannomed's total revenue was ₪117.00K, an increase of 368.00% from the same quarter last year. In Q4, Cannomed's net income was ₪-1.10M. See Cannomed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 685.00K₪ 131.00K₪ 142.00K₪ 60.00K₪ 658.00K
Gross Profit
₪ 539.00K₪ 131.00K₪ 142.00K₪ -5.93M₪ -10.22M
Operating Expenses
₪ 7.61M₪ 6.33M₪ 6.92M₪ 4.32M₪ 5.45M
Depreciation and Amortization
₪ 146.00K₪ 339.00K₪ 518.00K₪ 2.14M₪ 1.96M
EBITDA
₪ -1.91M₪ -5.58M₪ -6.11M₪ -16.48M₪ -18.18M
Operating Income
₪ -7.08M₪ -6.20M₪ -6.78M₪ -18.88M₪ -20.16M
Other Income/Expenses
₪ 194.00K₪ 717.00K₪ 111.00K₪ -146.00K₪ -894.00K
Pretax Income
₪ -6.88M₪ -6.20M₪ -6.67M₪ -19.02M₪ -21.05M
Net Income
₪ -5.12M₪ -5.07M₪ -6.91M₪ -20.08M₪ -13.43M
Per Share Metrics
Basic EPS
₪ -0.02₪ -0.02₪ -0.03₪ -0.20₪ -0.15
Diluted EPS
₪ -0.02₪ -0.02₪ -0.03₪ -0.20₪ -0.15
Weighted Average Shares Outstanding
326.70M 256.25M 251.19M 99.39M 88.04M
Weighted Average Shares Outstanding (Diluted)
326.70M 256.25M 215.64M 99.39M 88.04M
Currency in ILS

Cannomed Earnings and Revenue History